Variant report
Variant | nsv1018493 |
---|---|
Chromosome Location | chr9:9348853-9395912 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151111848 | chr9:9350038-9350039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192971454 | chr9:9350050-9350051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538485733 | chr9:9350057-9350058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550243504 | chr9:9350059-9350060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533021891 | chr9:9350065-9350066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547979005 | chr9:9350072-9350073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568959923 | chr9:9350089-9350090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535986119 | chr9:9350169-9350170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568384313 | chr9:9350181-9350182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554513740 | chr9:9350188-9350189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533855737 | chr9:9350199-9350200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578097569 | chr9:9350200-9350201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535325019 | chr9:9350213-9350214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553744063 | chr9:9350219-9350220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372711738 | chr9:9350263-9350264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139999578 | chr9:9350265-9350266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563896624 | chr9:9350275-9350276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557342093 | chr9:9350277-9350278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184483229 | chr9:9350318-9350319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542765442 | chr9:9350329-9350330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531623700 | chr9:9350351-9350352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561286622 | chr9:9350352-9350353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189138134 | chr9:9350363-9350364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114019421 | chr9:9351252-9351253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4742587 | chr9:9351254-9351255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182578503 | chr9:9351274-9351275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558481257 | chr9:9351277-9351278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141937148 | chr9:9351307-9351308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12345412 | chr9:9351319-9351320 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs375474911 | chr9:9351331-9351332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561738042 | chr9:9351357-9351358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185746743 | chr9:9351364-9351365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529877226 | chr9:9351370-9351371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190506069 | chr9:9351380-9351381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560314291 | chr9:9351387-9351388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527342824 | chr9:9351412-9351413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113761859 | chr9:9351429-9351430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552306910 | chr9:9351447-9351448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527452225 | chr9:9351470-9351471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571832008 | chr9:9351471-9351472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183086583 | chr9:9351476-9351477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10977676 | chr9:9351516-9351517 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs76697402 | chr9:9351520-9351521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370711091 | chr9:9351546-9351547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536974437 | chr9:9351556-9351557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548458431 | chr9:9351574-9351575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143046473 | chr9:9351596-9351597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188747390 | chr9:9351603-9351604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148264229 | chr9:9351620-9351621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542892855 | chr9:9351633-9351634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9350000-9350400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr9:9351200-9351600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr9:9351600-9352600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr9:9352600-9352800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr9:9384800-9385600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr9:9385200-9385600 | Enhancers | Stomach Mucosa | stomach |
7 | chr9:9385400-9385800 | Enhancers | Aorta | Aorta |
8 | chr9:9385600-9390800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
9 | chr9:9386800-9387200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr9:9387600-9387800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr9:9387800-9389600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr9:9389600-9390000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr9:9390000-9390800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr9:9390800-9391000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr9:9390800-9391000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr9:9391000-9391400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
17 | chr9:9391000-9391600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr9:9391400-9391800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr9:9391600-9392200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr9:9392600-9393200 | Active TSS | Rectal Mucosa Donor 29 | rectum |